|
DE10347710B4
(de)
|
2003-10-14 |
2006-03-30 |
Johannes-Gutenberg-Universität Mainz |
Rekombinante Impfstoffe und deren Verwendung
|
|
DE102005046490A1
(de)
|
2005-09-28 |
2007-03-29 |
Johannes-Gutenberg-Universität Mainz |
Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen
|
|
US9732131B2
(en)
|
2006-02-27 |
2017-08-15 |
Calviri, Inc. |
Identification and use of novopeptides for the treatment of cancer
|
|
RU2012111349A
(ru)
|
2009-08-24 |
2013-10-27 |
Байлор Колледж Оф Медсин |
Генерация линий ctl со специфичностью против множества опухолевых антигенов или множества вирусов
|
|
WO2011143656A2
(en)
*
|
2010-05-14 |
2011-11-17 |
The General Hospital Corporation |
Compositions and methods of identifying tumor specific neoantigens
|
|
WO2012159754A2
(en)
*
|
2011-05-24 |
2012-11-29 |
Biontech Ag |
Individualized vaccines for cancer
|
|
DK3473267T3
(da)
*
|
2011-05-24 |
2021-10-18 |
BioNTech SE |
Individualiserede vacciner mod cancer
|
|
JP6241735B2
(ja)
*
|
2011-08-02 |
2017-12-06 |
国立大学法人 東京大学 |
骨髄異形成症候群または骨髄性腫瘍の評価方法、そのポリペプチド及び抗体、並びにその治療薬若しくは予防薬の候補物スクリーニング方法
|
|
JP2014530013A
(ja)
*
|
2011-09-29 |
2014-11-17 |
トローバジーン インコーポレイテッド |
Ｓｆ３ｂ１遺伝子における変異および慢性リンパ性白血病
|
|
US20140364439A1
(en)
*
|
2011-12-07 |
2014-12-11 |
The Broad Institute, Inc. |
Markers associated with chronic lymphocytic leukemia prognosis and progression
|
|
GB201121308D0
(en)
|
2011-12-12 |
2012-01-25 |
Cell Medica Ltd |
Process
|
|
PL2812431T3
(pl)
|
2012-02-09 |
2020-02-28 |
Baylor College Of Medicine |
Mieszanki peptydowe do wytwarzania wielowirusowych CTL o szerokiej swoistości
|
|
WO2013143555A1
(en)
|
2012-03-26 |
2013-10-03 |
Biontech Ag |
Rna formulation for immunotherapy
|
|
CA2886218A1
(en)
|
2012-05-25 |
2013-11-28 |
Phosimmune, Inc. |
Identification of mhc class i phospho-peptide antigens from breast cancer utilizing shla technology and complementary enrichment strategies
|
|
AU2013289939B2
(en)
*
|
2012-07-12 |
2018-08-09 |
Persimmune, Inc. |
Personalized cancer vaccines and adoptive immune cell therapies
|
|
GB201214007D0
(en)
*
|
2012-08-07 |
2012-09-19 |
Scancell Ltd |
Anti-tumour immune responses to modified self-epitopes
|
|
AU2013308409A1
(en)
|
2012-08-31 |
2015-03-26 |
University Of Birmingham |
Target peptides for immunotherapy and diagnostics
|
|
EP4088737A3
(en)
|
2012-09-05 |
2023-02-08 |
University Of Virginia Patent Foundation |
Target peptides for colorectal cancer therapy and diagnostics
|
|
US10501801B2
(en)
|
2012-09-28 |
2019-12-10 |
University Of Connecticut |
Identification of tumor-protective epitopes for the treatment of cancers
|
|
EP2925348B1
(en)
|
2012-11-28 |
2019-03-06 |
BioNTech RNA Pharmaceuticals GmbH |
Individualized vaccines for cancer
|
|
GB2508414A
(en)
*
|
2012-11-30 |
2014-06-04 |
Max Delbrueck Centrum |
Tumour specific T cell receptors (TCRs)
|
|
BR122021025267B1
(pt)
|
2013-02-22 |
2023-12-05 |
Curevac Ag |
Partes de kit e composição farmacêutica compreendendo um inibidor da via de pd-1
|
|
CN105073135A
(zh)
|
2013-02-22 |
2015-11-18 |
库瑞瓦格有限责任公司 |
疫苗接种和抑制pd-1途径的组合
|
|
KR102164405B1
(ko)
|
2013-03-14 |
2020-10-12 |
더 존스 홉킨스 유니버시티 |
나노스케일 인공 항원 제시 세포
|
|
CN118750591A
(zh)
*
|
2013-04-07 |
2024-10-11 |
博德研究所 |
用于个性化瘤形成疫苗的组合物和方法
|
|
WO2014180490A1
(en)
|
2013-05-10 |
2014-11-13 |
Biontech Ag |
Predicting immunogenicity of t cell epitopes
|
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
US10801070B2
(en)
|
2013-11-25 |
2020-10-13 |
The Broad Institute, Inc. |
Compositions and methods for diagnosing, evaluating and treating cancer
|
|
WO2015085147A1
(en)
|
2013-12-05 |
2015-06-11 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
|
NZ721105A
(en)
*
|
2013-12-06 |
2022-04-29 |
Broad Inst Inc |
Formulations for neoplasia vaccines
|
|
BR112016014410A2
(pt)
*
|
2013-12-20 |
2018-02-20 |
The Broad Institute Inc. |
terapia de combinação com vacina de neoantígeno
|
|
US20160326597A1
(en)
*
|
2014-01-02 |
2016-11-10 |
Memorial Sloan Kettering Cancer Center |
Determinants of cancer response to immunotherapy
|
|
EP3116535B1
(en)
|
2014-03-12 |
2019-08-07 |
CureVac AG |
Combination of vaccination and ox40 agonists
|
|
AU2015247727A1
(en)
|
2014-04-15 |
2016-11-03 |
University Of Virginia Patent Foundation |
Isolated T cell receptors and methods of use therefor
|
|
CA2960834A1
(en)
|
2014-09-10 |
2016-03-17 |
Genentech, Inc. |
Immunogenic mutant peptide screening platform
|
|
EP3191121B1
(en)
*
|
2014-09-10 |
2020-05-27 |
The University of Connecticut |
Identification of immunologically protective neo-epitopes for the treatment of cancers
|
|
US11338026B2
(en)
|
2014-09-10 |
2022-05-24 |
The University Of Connecticut |
Identification of immunologically protective neo-epitopes for the treatment of cancers
|
|
EP3193892A4
(en)
*
|
2014-09-14 |
2018-09-12 |
Washington University |
Personalized cancer vaccines and methods therefor
|
|
DK3193917T3
(da)
*
|
2014-09-17 |
2021-10-04 |
Io Biotech Aps |
Vaccinesammensætninger, der omfatter tryptophan-2,3-dioxygenase eller fragmenter deraf
|
|
CN113791208B
(zh)
*
|
2014-09-17 |
2024-09-24 |
约翰·霍普金斯大学 |
用于识别、富集和/或扩增抗原特异性t细胞的试剂和方法
|
|
WO2016045732A1
(en)
|
2014-09-25 |
2016-03-31 |
Biontech Rna Pharmaceuticals Gmbh |
Stable formulations of lipids and liposomes
|
|
CN107075479A
(zh)
|
2014-10-02 |
2017-08-18 |
美国卫生和人力服务部 |
分离对癌症特异性突变具有抗原特异性的t细胞的方法
|
|
CN106999574B
(zh)
*
|
2014-10-10 |
2022-05-24 |
伊黛拉制药有限公司 |
使用tlr9激动剂与检查点抑制剂对癌症的治疗
|
|
MA40737A
(fr)
*
|
2014-11-21 |
2017-07-04 |
Memorial Sloan Kettering Cancer Center |
Déterminants de la réponse d'un cancer à une immunothérapie par blocage de pd-1
|
|
WO2016100975A1
(en)
|
2014-12-19 |
2016-06-23 |
Massachsetts Institute Ot Technology |
Molecular biomarkers for cancer immunotherapy
|
|
US10993997B2
(en)
|
2014-12-19 |
2021-05-04 |
The Broad Institute, Inc. |
Methods for profiling the t cell repertoire
|
|
WO2016128060A1
(en)
*
|
2015-02-12 |
2016-08-18 |
Biontech Ag |
Predicting t cell epitopes useful for vaccination
|
|
AU2016238290B9
(en)
|
2015-03-25 |
2019-06-13 |
The Regents Of The University Of Michigan |
Compositions and methods for delivery of biomacromolecule agents
|
|
CA2987730C
(en)
*
|
2015-04-08 |
2020-02-18 |
Nantomics, Llc |
Cancer neoepitopes
|
|
BR112017022845A2
(pt)
|
2015-04-23 |
2018-07-17 |
Nantomics, Llc |
neoepítopos de câncer
|
|
GB201507030D0
(en)
|
2015-04-24 |
2015-06-10 |
Immatics Biotechnologies Gmbh |
Immunotherapy against lung cancers, in particular NSCLC
|
|
SG11201707920YA
(en)
*
|
2015-04-27 |
2017-11-29 |
Cancer Research Tech Ltd |
Method for treating cancer
|
|
CA2984234C
(en)
|
2015-05-01 |
2023-10-10 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of isolating t cells and t cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood
|
|
CN107847572A
(zh)
|
2015-05-13 |
2018-03-27 |
艾吉纳斯公司 |
用于癌症治疗和预防的疫苗
|
|
HK1252267A1
(zh)
*
|
2015-05-20 |
2019-05-24 |
The Broad Institute Inc. |
共有的新抗原
|
|
TWI750122B
(zh)
*
|
2015-06-09 |
2021-12-21 |
美商博德研究所有限公司 |
用於贅瘤疫苗之調配物及其製備方法
|
|
EP3323070B1
(en)
|
2015-07-14 |
2024-05-08 |
Personal Genome Diagnostics Inc. |
Neoantigen analysis
|
|
MA42543A
(fr)
|
2015-07-30 |
2018-06-06 |
Modernatx Inc |
Arn épitope peptidiques concatémériques
|
|
GB201516047D0
(en)
*
|
2015-09-10 |
2015-10-28 |
Cancer Rec Tech Ltd |
Method
|
|
WO2017049291A1
(en)
|
2015-09-18 |
2017-03-23 |
Baylor College Of Medicine |
Immunogenic antigen identification from a pathogen and correlation to clinical efficacy
|
|
WO2017059902A1
(en)
|
2015-10-07 |
2017-04-13 |
Biontech Rna Pharmaceuticals Gmbh |
3' utr sequences for stabilization of rna
|
|
AU2016339924B2
(en)
|
2015-10-12 |
2020-01-02 |
Nantomics, Llc |
Compositions and methods for viral cancer neoepitopes
|
|
WO2017066357A1
(en)
|
2015-10-12 |
2017-04-20 |
Nantomics, Llc |
Systems, compositions, and methods for discovery of msi and neoepitopes that predict sensitivity to checkpoint inhibitors
|
|
CN108604257B
(zh)
*
|
2015-10-12 |
2022-12-13 |
南托米克斯有限责任公司 |
产生特异性免疫治疗组合物及其相关核酸构建体的方法
|
|
WO2017066339A1
(en)
|
2015-10-12 |
2017-04-20 |
Nantomics, Llc |
Iterative discovery of neoepitopes and adaptive immunotherapy and methods therefor
|
|
WO2017070618A1
(en)
*
|
2015-10-22 |
2017-04-27 |
Modernatx, Inc. |
Cancer vaccines
|
|
KR102696044B1
(ko)
|
2015-11-06 |
2024-08-16 |
벤타나 메디컬 시스템즈, 인코포레이티드 |
대표 진단법
|
|
TWI733719B
(zh)
|
2015-12-07 |
2021-07-21 |
美商河谷控股Ｉｐ有限責任公司 |
改善的組合物及用於新表位之病毒遞送的方法及其應用
|
|
KR102883915B1
(ko)
*
|
2015-12-16 |
2025-11-18 |
시애틀 프로젝트 코포레이션 |
신생항원 동정, 제조, 및 용도
|
|
JP2019502753A
(ja)
*
|
2015-12-23 |
2019-01-31 |
ムーンショット ファーマ エルエルシー |
ナンセンス変異依存ｍＲＮＡ分解機構の抑制による免疫応答の誘導法
|
|
KR102833333B1
(ko)
|
2016-01-08 |
2025-07-11 |
니코데 테라퓨틱스 에이에스에이 |
치료적 항암 네오에피토프 백신
|
|
US20170224796A1
(en)
|
2016-02-05 |
2017-08-10 |
Xeme Biopharma Inc. |
Therapeutic Cancer Vaccine Containing Tumor-Associated Neoantigens and Immunostimulants in a Delivery System
|
|
SG11201806282XA
(en)
|
2016-02-12 |
2018-08-30 |
Nantomics Llc |
High-throughput identification of patient-specific neoepitopes as therapeutic targets for cancer immunotherapies
|
|
CN105720176A
(zh)
*
|
2016-02-19 |
2016-06-29 |
京东方科技集团股份有限公司 |
一种胶囊量子点和发光二极管、制备方法及显示装置
|
|
AU2017219901B2
(en)
*
|
2016-02-19 |
2022-07-14 |
Nant Holdings Ip, Llc |
Methods of immunogenic modulation
|
|
MX2018011491A
(es)
*
|
2016-03-24 |
2019-08-01 |
Nantcell Inc |
Disposiciones de secuencia y secuencias para presentacion de neoepitopos.
|
|
CA3056212A1
(en)
*
|
2016-04-07 |
2017-10-12 |
Bostongene Corporation |
Construction and methods of use of a therapeutic cancer vaccine library comprising fusion-specific vaccines
|
|
WO2017180769A1
(en)
*
|
2016-04-13 |
2017-10-19 |
Capten Therapeutics Inc. |
Small molecules for immunogenic treatment of cancer
|
|
US12257352B2
(en)
|
2016-06-20 |
2025-03-25 |
The Regents Of The University Of Michigan |
Compositions and methods for delivery of biomacromolecule agents
|
|
US20190247435A1
(en)
*
|
2016-06-29 |
2019-08-15 |
The Johns Hopkins University |
Neoantigens as targets for immunotherapy
|
|
DK3484448T3
(da)
|
2016-07-13 |
2025-06-10 |
Harvard College |
Antigenpræsenterende cellemimetiske stilladser og fremgangsmåder til fremstilling og brug af disse
|
|
IL264203B2
(en)
*
|
2016-07-20 |
2024-08-01 |
Biontech Rna Pharmaceuticals Gmbh |
Selecting neoepitopes as disease-specific targets for therapy with enhanced efficacy
|
|
WO2018026914A1
(en)
*
|
2016-08-02 |
2018-02-08 |
Nantcell, Inc. |
Transfection of dendritic cells and methods therefor
|
|
US10350280B2
(en)
|
2016-08-31 |
2019-07-16 |
Medgenome Inc. |
Methods to analyze genetic alterations in cancer to identify therapeutic peptide vaccines and kits therefore
|
|
US20190237158A1
(en)
*
|
2016-08-31 |
2019-08-01 |
Medgenome, Inc. |
Methods to analyze genetic alterations in cancer to identify therapeutic peptide vaccines and kits therefore
|
|
IL292658A
(en)
|
2016-09-15 |
2022-07-01 |
Idera Pharmaceuticals Inc |
Immune modulation with tlr9 agonists for cancer treatment
|
|
EP3516045A1
(en)
*
|
2016-09-23 |
2019-07-31 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Methods of preparing an isolated population of dendritic cells and methods of treating cancer using same
|
|
US20190240257A1
(en)
*
|
2016-10-13 |
2019-08-08 |
The Johns Hopkins University |
Compositions and methods for identifying functional anti-tumor t cell responses
|
|
CN110520530A
(zh)
*
|
2016-10-18 |
2019-11-29 |
明尼苏达大学董事会 |
肿瘤浸润性淋巴细胞和治疗方法
|
|
US20190321481A1
(en)
|
2016-11-11 |
2019-10-24 |
Nantbio, Inc. |
Immunomodulatory compositions, processes for making the same, and methods for inhibiting cytokine storms
|
|
CN110214275B
(zh)
|
2016-12-01 |
2022-12-06 |
南托米克斯有限责任公司 |
肿瘤抗原性加工和呈递
|
|
WO2018140391A1
(en)
|
2017-01-24 |
2018-08-02 |
The Broad Institute, Inc. |
Compositions and methods for detecting a mutant variant of a polynucleotide
|
|
RU2022106357A
(ru)
*
|
2017-02-01 |
2022-03-24 |
МОДЕРНАТиЭкс, ИНК. |
Противораковые рнк-вакцины
|
|
KR20190110612A
(ko)
*
|
2017-02-01 |
2019-09-30 |
모더나티엑스, 인크. |
활성화 종양유전자 돌연변이 펩티드를 인코드하는 면역조절 치료 mrna 조성물
|
|
EP3601536A4
(en)
|
2017-03-20 |
2021-01-13 |
Genocea Biosciences, Inc. |
TREATMENT PROCEDURES
|
|
WO2018183544A1
(en)
*
|
2017-03-31 |
2018-10-04 |
Dana-Farber Cancer Institute, Inc. |
Method for identification of retained intron tumor neoantigens from patient transcriptome
|
|
CA3058807A1
(en)
|
2017-04-03 |
2018-10-11 |
Neon Therapeutics, Inc. |
Protein antigens and uses thereof
|
|
KR20240149976A
(ko)
|
2017-04-04 |
2024-10-15 |
바린투스 바이오테라퓨틱스 노쓰 아메리카, 인크. |
펩티드-기반 백신, 그의 제조 방법, 및 면역 반응을 유도하기 위한 그의 용도
|
|
BR112019021782A2
(pt)
*
|
2017-04-19 |
2020-08-18 |
Gritstone Oncology, Inc. |
identificação, fabricação e uso de neoantígenos
|
|
IL270132B2
(en)
|
2017-04-24 |
2024-12-01 |
Nantcell Inc |
Neoepitope vectors and methods for them
|
|
WO2018208856A1
(en)
|
2017-05-08 |
2018-11-15 |
Gritstone Oncology, Inc. |
Alphavirus neoantigen vectors
|
|
US20200199660A1
(en)
|
2017-05-10 |
2020-06-25 |
The Broad Institute, Inc. |
Methods and compositions for determination of mutations in single replication events
|
|
WO2018209324A2
(en)
|
2017-05-11 |
2018-11-15 |
The Broad Institute, Inc. |
Methods and compositions of use of cd8+ tumor infiltrating lymphocyte subtypes and gene signatures thereof
|
|
WO2018223094A1
(en)
*
|
2017-06-02 |
2018-12-06 |
Arizona Board Of Regents On Behalf Of Arizona State University |
A method to create personalized canine cancer vaccines
|
|
WO2018224166A1
(en)
|
2017-06-09 |
2018-12-13 |
Biontech Rna Pharmaceuticals Gmbh |
Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy
|
|
WO2018234506A2
(en)
*
|
2017-06-21 |
2018-12-27 |
Transgene Sa |
PERSONALIZED VACCINE
|
|
WO2019014581A1
(en)
|
2017-07-14 |
2019-01-17 |
The Broad Institute, Inc. |
METHODS AND COMPOSITIONS FOR MODULATING THE ACTIVITY OF A CYTOTOXIC LYMPHOCYTE
|
|
EP4620977A3
(en)
|
2017-07-21 |
2025-12-17 |
Bruker Cellular Analysis, Inc. |
Antigen-presenting synthetic surfaces, covalently functionalized surfaces, activated t cells, and uses thereof
|
|
CN111727262A
(zh)
|
2017-07-25 |
2020-09-29 |
加州理工学院 |
胞啃介导的表位发现
|
|
WO2019036043A2
(en)
*
|
2017-08-16 |
2019-02-21 |
Medgenome Inc. |
METHOD FOR GENERATING A COCKTAIL OF PERSONALIZED ANTICANCER VACCINES FROM TUMOR DERIVED GENETIC MODIFICATIONS FOR THE TREATMENT OF CANCER
|
|
US12025615B2
(en)
|
2017-09-15 |
2024-07-02 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods of classifying response to immunotherapy for cancer
|
|
US20200362418A1
(en)
*
|
2017-10-02 |
2020-11-19 |
Curematch, Inc. |
Method of prediction of tumor-derived neo-peptide antigenicity and/or immunogenicity using mutational signature patterns
|
|
BR112020006879A2
(pt)
*
|
2017-10-06 |
2020-10-06 |
The Wistar Institute Of Anatomy And Biology |
composição para gerar um ou mais anticorpos anti-ctla-4 ou fragmentos dos mesmos em um sujeito, e, métodos para tratar uma doença em um sujeito e para aumentar uma resposta imune em um sujeito em necessidade do mesmo
|
|
JP7227237B2
(ja)
|
2017-10-10 |
2023-02-21 |
グリットストーン バイオ インコーポレイテッド |
ホットスポットを利用した新生抗原の特定
|
|
CA3081479A1
(en)
*
|
2017-11-06 |
2019-05-09 |
Ludwig Institute For Cancer Research Ltd |
Method for expansion of lymphocytes
|
|
EP3706770A4
(en)
*
|
2017-11-07 |
2021-10-27 |
Nektar Therapeutics |
IMMUNOTHERAPEUTIC COMBINATION FOR THE TREATMENT OF CANCER
|
|
EP3706784A4
(en)
|
2017-11-08 |
2021-12-01 |
BioNTech US Inc. |
COMPOSITIONS AND METHODS OF MANUFACTURING T-CELLS
|
|
US11885815B2
(en)
|
2017-11-22 |
2024-01-30 |
Gritstone Bio, Inc. |
Reducing junction epitope presentation for neoantigens
|
|
CN109682978B
(zh)
*
|
2017-11-30 |
2020-07-03 |
四川康德赛医疗科技有限公司 |
一种肿瘤突变肽mhc亲和力预测方法及其应用
|
|
US11793867B2
(en)
|
2017-12-18 |
2023-10-24 |
Biontech Us Inc. |
Neoantigens and uses thereof
|
|
CN118955721A
(zh)
|
2018-01-04 |
2024-11-15 |
伊科尼克治疗公司 |
抗组织因子抗体、抗体-药物缀合物及相关方法
|
|
WO2019147921A1
(en)
|
2018-01-26 |
2019-08-01 |
Nantcell, Inc. |
Rapid verification of virus particle production for a personalized vaccine
|
|
EP3743102A1
(en)
|
2018-01-26 |
2020-12-02 |
Nantcell, Inc. |
Compositions and methods for combination cancer vaccine and immunologic adjuvant therapy
|
|
CN108491689B
(zh)
*
|
2018-02-01 |
2019-07-09 |
杭州纽安津生物科技有限公司 |
基于转录组的肿瘤新抗原鉴定方法
|
|
CN119851752A
(zh)
*
|
2018-02-27 |
2025-04-18 |
磨石生物公司 |
利用泛等位基因模型进行的新抗原鉴别
|
|
CN112218883A
(zh)
|
2018-04-26 |
2021-01-12 |
艾吉纳斯公司 |
热休克蛋白结合肽组合物及其使用方法
|
|
CA3100974A1
(en)
*
|
2018-05-25 |
2020-11-28 |
The Wistar Institute |
Tumor-specific neoantigens and methods of using the same
|
|
US20220403001A1
(en)
|
2018-06-12 |
2022-12-22 |
Obsidian Therapeutics, Inc. |
Pde5 derived regulatory constructs and methods of use in immunotherapy
|
|
TW202015719A
(zh)
|
2018-06-19 |
2020-05-01 |
美商尼恩醫療公司 |
新抗原及其用途
|
|
CA3106564A1
(en)
|
2018-07-26 |
2020-01-30 |
Frame Pharmaceuticals B.V. |
Cancer vaccines for breast cancer
|
|
WO2020022903A1
(en)
|
2018-07-26 |
2020-01-30 |
Frame Pharmaceuticals B.V. |
ARID1A, CDKN2A, KMT2B, KMT2D, TP53 and PTEN VACCINES FOR CANCER
|
|
WO2020022900A1
(en)
|
2018-07-26 |
2020-01-30 |
Frame Pharmaceuticals B.V. |
Cancer vaccines for kidney cancer
|
|
US20220349010A1
(en)
|
2018-07-26 |
2022-11-03 |
Frame Pharmaceuticals B.V. |
Method of preparing subject-specific immunogenic compositions based on a neo open-reading-frame peptide database
|
|
IL280115B2
(en)
|
2018-07-26 |
2025-11-01 |
Curevac Netherlands B V |
Cancer vaccines for colorectal cancer
|
|
IL280113B2
(en)
|
2018-07-26 |
2025-11-01 |
Curevac Netherlands B V |
Cancer vaccines for uterine cancer
|
|
CN109021062B
(zh)
*
|
2018-08-06 |
2021-08-20 |
倍而达药业（苏州）有限公司 |
一种肿瘤新抗原的筛选方法
|
|
AU2019328344B2
(en)
|
2018-08-31 |
2025-06-12 |
Guardant Health, Inc. |
Microsatellite instability detection in cell-free DNA
|
|
GB201815041D0
(en)
|
2018-09-14 |
2018-10-31 |
Scancell Ltd |
Epitopes
|
|
US11945850B2
(en)
*
|
2018-09-17 |
2024-04-02 |
Immatics Biotechnologies Gmbh |
B*44 restricted peptides for use in immunotherapy against cancers and related methods
|
|
US11993766B2
(en)
|
2018-09-21 |
2024-05-28 |
Bruker Cellular Analysis, Inc. |
Functionalized well plate, methods of preparation and use thereof
|
|
BR112021005702A8
(pt)
|
2018-09-27 |
2022-11-08 |
Vaccibody As |
Método para selecionar neoepítopos
|
|
CA3115531A1
(en)
|
2018-10-18 |
2020-04-23 |
Berkeley Lights, Inc. |
Proto-antigen-presenting synthetic surfaces, activated t cells, and uses thereof
|
|
JP2022512948A
(ja)
|
2018-11-08 |
2022-02-07 |
ネクシミューン インコーポレイテッド |
表現型特性が向上したｔ細胞組成物
|
|
WO2020131586A2
(en)
|
2018-12-17 |
2020-06-25 |
The Broad Institute, Inc. |
Methods for identifying neoantigens
|
|
CN109706065A
(zh)
*
|
2018-12-29 |
2019-05-03 |
深圳裕策生物科技有限公司 |
肿瘤新生抗原负荷检测装置及存储介质
|
|
BR112021016451A2
(pt)
|
2019-02-20 |
2021-11-09 |
Rubius Therapeutics Inc |
Célula eritroide projetada incluindo polipeptídeos apresentadores de antígeno carregáveis e métodos de uso
|
|
CN111621564B
(zh)
*
|
2019-02-28 |
2022-03-25 |
武汉大学 |
一种鉴定有效肿瘤新抗原的方法
|
|
US12427195B1
(en)
*
|
2019-03-11 |
2025-09-30 |
La Jolla Institute For Immunology |
Methods of neoantigen identification
|
|
US20220130489A1
(en)
*
|
2019-03-12 |
2022-04-28 |
Syntekabio,Inc. |
System and method for providing neoantigen immunotherapy information by using artificial-intelligence-model-based molecular dynamics big data
|
|
EP3963335B1
(en)
*
|
2019-05-03 |
2024-08-21 |
Epivax Therapeutics, Inc. |
Neoantigens in cancer
|
|
EP3966323A4
(en)
*
|
2019-05-06 |
2024-04-24 |
The Regents Of The University Of Michigan |
TARGETED THERAPY
|
|
CN112011833B
(zh)
*
|
2019-05-30 |
2024-04-26 |
上海桀蒙生物技术有限公司 |
筛选和分离肿瘤新生抗原的方法
|
|
BR122024002387A2
(pt)
|
2019-05-30 |
2024-03-12 |
Gritstone Bio, Inc. |
Vetores de adenovírus, composição farmacêutica, sequência de nucleotídeo isolada, célula isolada, vetor, kit, usos de um vetor, método para fabricar o vetor, métodos para produzir um vírus e vetor viral
|
|
CN110322925B
(zh)
*
|
2019-07-18 |
2021-09-03 |
杭州纽安津生物科技有限公司 |
一种预测融合基因产生新生抗原的方法
|
|
CN110706747B
(zh)
*
|
2019-09-17 |
2021-09-07 |
北京橡鑫生物科技有限公司 |
检测肿瘤新生抗原多肽的方法和装置
|
|
EP4038222A4
(en)
|
2019-10-02 |
2023-10-18 |
Arizona Board of Regents on behalf of Arizona State University |
Methods and compositions for identifying neoantigens for use in treating and preventing cancer
|
|
US11920202B2
(en)
|
2020-04-09 |
2024-03-05 |
University Of Connecticut |
Unbiased identification of tumor rejection mediating neoepitopes
|
|
WO2021228999A1
(en)
*
|
2020-05-12 |
2021-11-18 |
Institut Curie |
Neoantigenic epitopes associated with sf3b1 mutations
|
|
MX2022014249A
(es)
*
|
2020-05-12 |
2023-02-22 |
Sumitomo Pharma Co Ltd |
Composición farmacéutica para tratar el cáncer.
|
|
WO2021252904A1
(en)
|
2020-06-11 |
2021-12-16 |
Massachusetts Institute Of Technology |
Ribonucleoprotein approach to boost the sting signaling for cancer immunotherapy
|
|
WO2022032196A2
(en)
|
2020-08-06 |
2022-02-10 |
Gritstone Bio, Inc. |
Multiepitope vaccine cassettes
|
|
CU20230011A7
(es)
|
2020-08-13 |
2023-12-07 |
Biontech Us Inc |
Composiciones y métodos de fabricación de células t
|
|
GB2613718A
(en)
*
|
2020-08-31 |
2023-06-14 |
World Biotech Regenerative Medical Group Ltd |
Personalized immunogenic compositions and methods for producing and using same
|
|
KR102552632B1
(ko)
*
|
2020-11-06 |
2023-07-06 |
사회복지법인 삼성생명공익재단 |
중추신경계 림프종을 진단하기 위한 마커, 이를 포함하는 중추신경계 림프종 진단 키트 및 중추신경계 림프종을 진단하는 방법
|
|
CN117479951A
(zh)
*
|
2021-03-26 |
2024-01-30 |
转化基因组学研究所 |
用于新抗原疫苗的方法和化合物
|
|
CA3214450A1
(en)
|
2021-04-30 |
2022-11-03 |
Tigen Pharma Sa |
Single vessel expansion of lymphocytes
|
|
JP2024520477A
(ja)
*
|
2021-05-27 |
2024-05-24 |
アマゾン テクノロジーズ インコーポレイテッド |
ペプチドに基づくネオ抗原ワクチンの多成分化学組成物
|
|
WO2023025404A1
(en)
|
2021-08-24 |
2023-03-02 |
BioNTech SE |
In vitro transcription technologies
|
|
CN115772564B
(zh)
*
|
2021-09-08 |
2023-08-18 |
广州市基准医疗有限责任公司 |
用于辅助检测肺癌体细胞atm基因融合突变的甲基化生物标记物及其应用
|
|
US20240417805A1
(en)
|
2021-10-21 |
2024-12-19 |
Curevac Netherlands B.V. |
Cancer neoantigens
|
|
CN116287158A
(zh)
*
|
2021-12-08 |
2023-06-23 |
初源海生物科技(深圳)有限公司 |
一种新抗原鉴定和疗效预测方法
|
|
CA3245737A1
(en)
|
2022-03-14 |
2023-09-21 |
Generation Bio Co. |
PRIME-BOOST HETEROLOGICAL VACCINE COMPOSITIONS AND METHODS OF USE
|
|
WO2024077256A1
(en)
|
2022-10-07 |
2024-04-11 |
The General Hospital Corporation |
Methods and compositions for high-throughput discovery ofpeptide-mhc targeting binding proteins
|
|
WO2024083345A1
(en)
|
2022-10-21 |
2024-04-25 |
BioNTech SE |
Methods and uses associated with liquid compositions
|
|
AU2023372974A1
(en)
|
2022-11-02 |
2025-06-12 |
Centre Hospitalier Universitaire Vaudois (Chuv) |
Expansion of lymphocytes
|
|
US12531162B1
(en)
*
|
2023-05-31 |
2026-01-20 |
Northeastern University |
Multi-dimensional phenotypic space for genotype to phenotype mapping and intelligent design of cancer drug therapies using a deep learning net
|
|
EP4474016A1
(en)
|
2023-06-07 |
2024-12-11 |
Julius-Maximilians-Universität Würzburg |
Strategies to target extracellularly accessible ras protein
|
|
WO2024261339A1
(en)
|
2023-06-23 |
2024-12-26 |
Tigen Pharma Sa |
Lymphocyte-stimulatory matrix (lsm) and uses thereof for expansion of lymphocyte populations
|
|
WO2025202937A1
(en)
|
2024-03-26 |
2025-10-02 |
BioNTech SE |
Cancer vaccines
|